Cargando…

Fluvoxamine

Detalles Bibliográficos
Autor principal:	DeVane, C Lindsay
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2005
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2424116/ https://www.ncbi.nlm.nih.gov/pubmed/18568109

Ejemplares similares

Management of obsessive-compulsive disorder with fluvoxamine extended release
por: Ordacgi, Lídia, et al.
Publicado: (2009)

Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence
por: Facente, Shelley N., et al.
Publicado: (2021)

Fluvoxamine in the treatment of anxiety disorders
por: Irons, Jane
Publicado: (2005)

Fluvoxamine, melatonin and COVID-19
por: Anderson, George M.
Publicado: (2021)

Fluvoxamine for the treatment of COVID-19
por: Dodds, Michael G, et al.
Publicado: (2022)

Fluvoxamine for the treatment of COVID-19
por: Boulware, David R, et al.
Publicado: (2022)

Fluvoxamine for the treatment of COVID-19
por: Kim, Hyun, et al.
Publicado: (2022)

Fluvoxamine for the treatment of COVID-19
por: Marzolini, Catia, et al.
Publicado: (2022)

Tolerability and safety of fluvoxamine and other antidepressants
por: Westenberg, HGM, et al.
Publicado: (2006)

Fluvoxamine alleviates paclitaxel-induced neurotoxicity
por: Tanimukai, Hitoshi, et al.
Publicado: (2015)

Fluvoxamine for symptomatic outpatients with COVID-19
por: Wu, Peter E., et al.
Publicado: (2022)

Fluvoxamine for the treatment of COVID-19 – Author's reply
por: Reis, Gilmar, et al.
Publicado: (2022)

Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine
por: Oka, Takakazu, et al.
Publicado: (2007)

Old drug fluvoxamine, new hope for COVID-19
por: Hashimoto, Yaeko, et al.
Publicado: (2021)

Correspondence on Fluvoxamine Treatment of Patients with Symptomatic COVID-19
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Early Treatment with Fluvoxamine among Patients with COVID-19: A Cost-Consequence Model
por: Mills, Fergal P., et al.
Publicado: (2023)

Pharmacokinetic Modeling of Non-Linear Brain Distribution of Fluvoxamine in the Rat
por: Geldof, Marian, et al.
Publicado: (2007)

Pilot study of fluvoxamine treatment for climacteric symptoms in Japanese women
por: Oishi, Akira, et al.
Publicado: (2007)

Study of the Effect of Nortriptyline and Fluvoxamine on Psychomotor Functions in Healthy Volunteers
por: Khade, Ajay, et al.
Publicado: (2010)

Fluvoxamine Attenuated Endoplasmic Reticulum Stress-Induced Leptin Resistance
por: Hosoi, Toru, et al.
Publicado: (2012)

Emergence of kleptomania during treatment for obsessive compulsive disorder with fluvoxamine
por: Gupta, Parveen Rani
Publicado: (2014)

Olfactory Reference Syndrome with Suicidal Attempt Treated with Pimozide and Fluvoxamine
por: Jegede, Oluwole, et al.
Publicado: (2018)

Prospective Cohort of Fluvoxamine for Early Treatment of Coronavirus Disease 19
por: Seftel, David, et al.
Publicado: (2021)

Fluvoxamine for outpatients with COVID-19: where do we stand?
por: Berwanger, Otavio
Publicado: (2022)

Potential Role of the Antidepressants Fluoxetine and Fluvoxamine in the Treatment of COVID-19
por: Mahdi, Mohamed, et al.
Publicado: (2022)

Mechanisms of action of fluvoxamine for COVID-19: a historical review
por: Hashimoto, Yaeko, et al.
Publicado: (2022)

Reply: Correspondence on Fluvoxamine Treatment of Patients with Symptomatic COVID-19
por: Seo, Hyeonji, et al.
Publicado: (2022)

Overview of the potential use of fluvoxamine for COVID-19 and long COVID
por: Hashimoto, Kenji
Publicado: (2023)

Improvement of tardive dyskinesia in a depressive patient treated with fluvoxamine
por: Dzhupanov, G.
Publicado: (2023)

Risperidone and fluvoxamine; two directions of augmentation: a case report
por: Štracak, M., et al.
Publicado: (2023)

Fluvoxamine for blonanserin-associated akathisia in patients with schizophrenia: report of five cases
por: Furuse, Tsutomu, et al.
Publicado: (2010)

Fluvoxamine monotherapy for psychotic depression: the potential role of sigma-1 receptors
por: Furuse, Tsutomu, et al.
Publicado: (2009)

Sigma-1 receptor agonist fluvoxamine for delirium in patients with Alzheimer's disease
por: Furuse, Tsutomu, et al.
Publicado: (2010)

Haloperidol augmentation of fluvoxamine in skin picking disorder: a case report
por: Luca, Maria, et al.
Publicado: (2012)

Fluvoxamine alleviates ER stress via induction of Sigma-1 receptor
por: Omi, T, et al.
Publicado: (2014)

Effect of combination of aripiprazole with carbamazepine and fluvoxamine on liver functions in experimental animals
por: Shastry, Chakrakodi S., et al.
Publicado: (2013)

Fluvoxamine-induced intracranial hypertension in a 10-year-old boy
por: Samant, Hemalini, et al.
Publicado: (2018)

Gastroprotective and antioxidant effects of fluvoxamine on stress-induced peptic ulcer in rats
por: Elsaed, Wael M., et al.
Publicado: (2018)

Thermal Stability and Kinetic Study of Fluvoxamine Stability in Binary Samples with Lactose
por: Ghaderi, Faranak, et al.
Publicado: (2017)

Heme oxygenase agonists—fluvoxamine, melatonin—are efficacious therapy for Covid-19
por: Hooper, Philip L.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g4p86he05avl12lldtmqnhpvav